Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient

Transfusion

Volumn 38, Issue 7, 1998, Pages 637-644

  Hersh, J K ^a,b,c   Hom, E G ^d,e   Brecher, M E ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Brigham and Women's/Faulkner Hospitals   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; DOSE RESPONSE; MATHEMATICAL MODEL; PRACTICE GUIDELINE; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTE TRANSFUSION; THROMBOCYTHEMIA; TREATMENT INDICATION;

EID: 0031824374     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38798346631.x     Document Type: Article

References (22)

1. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
2. George JN, Morgan RK. Platelet behavior and aging in the circulation. In: Greenwalt TJ, Jamieson GA, eds. The blood platelet in transfusion therapy. New York: Alan R. Liss, 1978:39-64.
3. Gimbrone MA Jr, Aster RH, Cotran RS, et al. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222:33-6.
4. Dodds WJ, Raymond SL, Pert JH, Hall CA. Isolated kidney perfusion: a model for testing platelet function. Proc Soc Exp Biol Med 1973;144:189-94.
5. Johnson SA. The circulating platelet. New York: Academic Press, 1971:283-99.
6. Kitchens CS. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest 1977;60:1129-34.
7. Ritchie JL, Harker LA. Platelet and flbrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol 1977;39:595-8.
8. Tomer A, Hanson SR, Harker LA. Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. J Lab Clin Med 1991;118:6:546-54.
9. Mills JN. The life-span of the erythrocyte. J Physiol Soc 1946;105:16-7.
10. Dornhorst AC. The interpretation of red cell survival curves. Blood 1951;6:1284-92.
11. Branehog I, Ridell B, Weinfeld A. On the analysis of platelet survival curves and the calculation of platelet production and destruction. Scand J Haematol 1977;19:230-41.
12. Bautista AP, Buckler PW, Towler HM, et al. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets. Br J Haematol 1984;58:679-87.
13. Brodsky I, Kahn SB, Ross EM, Petkov G. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders. Cancer 1972;30:1444-50.
14. Lotter MG. Measurement of platelet survival and analysis of survival curves. In: du P Heyns A, Badenhorst PN, Lotter MG, eds. Platelet kinetics and imaging, vol. 1. Boca Raton, FL: CRC Press, 1985.
15. Ballem PJ, Segal GM, Stratton JR, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987;80:33-40.
16. Harker LA. The kinetics of platelet production and destruction in man. Clin Haematol 1977;6:671-93.
17. Rees GJ, Slade RR, Hopes P. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma. Eur J Cancer Clin Oncol 1982;18:1125-9.
18. Kumar A, Khanna NN, Khanna S, Gupta YN. Qualitative platelet dysfunction following cancer chemotherapy: a case report. J Surg Oncol 1984;25:176-7.
19. Abrahamsen AF, Klepp O, Fossa SD, Sonstevold A. Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin. Scand J Haematol 1986;37:44-9.
20. Goldberg GL, Gibbon DG, Smith HO, et al. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer. J Clin Oncol 1994;12:2317-20.
21. Herman JH, Klumpp TR, Christman RA, et al. The effect of platelet dose on the outcome of prophylactic platelet transfusion (abstract). Transfusion 1995;35(Suppl):46S.
22. Petz LD. Platelet transfusions. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds. Clinical practice of transfusion medicine. London: Churchill Livingstone, 1996:359-412.